Key Record Dates
| ClinicalTrials.gov Identifier: | NCT03929029 |
|---|---|
| Brief Title: | Neoantigen Vaccine Plus Locally Administered Ipilimumab and Systemic Nivolumab in Advanced Melanoma |
| First Submitted : | April 2, 2019 |
| First Submitted that Met QC Criteria : | April 25, 2019 |
| First Posted : | April 26, 2019 |
| Last Update Submitted that Met QC Criteria : | January 16, 2024 |
| Last Update Posted : | January 18, 2024 |